Clinical Trial Update: Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating venetoclax in combination with carfilzomib and dexamethasone in relapsed or refractory multiple myeloma; the trial is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)
• Venetoclax (venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING